Skip to main content
. 2022 Apr 25;17:24. doi: 10.1186/s13722-022-00303-8

Table 2.

COVID-19 survey participants baseline characteristics (n = 50), 2018–2021

n (%)
Demographics
Age (mean, SD) 40.4 (SD 10.0)
Gender
 Male 26 (52.0%)
 Female 24 (48.0%)
Race/Ethnicity
 White 44 (88.0%)
 Black 5 (10.0%)
 American Indian/Alaska Native 1 (2.0%)
 Latino/Hispanic 0 (0.0%)
Education
 Elementary 7 (14.0)
 Some high school 21 (42.0)
 High school graduate 16 (32.0)
 Some college/technical 5 (10.0)
 Missing 1 (2.0)
Homeless (last 6 months) 31 (62.0%)
Accessed Food Supports (last 6 months) 46 (92.0%)
Overdose questions
 Ever experienced an overdose 27 (54.0%)
 Lifetime number of overdose(s) experienced (mean, SD) 3.5 (SD 6.1)
 Lifetime number of overdose(s) experienced [median, IQR] 2 [1, 3]
 Witnessed an overdose 38 (76.0%)
 Have you ever been trained to recognize and respond to an overdose? 24 (48.0%)
 Have you ever called 911 because someone overdosed? 23 (46.0%)
 Have you ever gotten an overdose reversal kit or prescription for naloxone or Narcan? 25 (50.0%)
 Have you ever used naloxone or Narcan on someone to reverse an overdose?* (n = 39) 19 (48.7%)
 Do you currently have naloxone or Narcan with you or at home?* (n = 39) 26 (66.7%)
 How many people you know have died from an overdose in the past 6 months? 2.1 (SD 3.0)

*Not all 50 participants were asked this question given a branching logic for participants enrolled in the UG3 study